Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sani Kizilbash"'
Autor:
Jann N. Sarkaria, William F. Elmquist, Nicola J. Curtin, Nathalie Y.R. Agar, Alan V. Boddy, Julieann Sludden, Mark A. Schroeder, Brett L. Carlson, Rajendar K. Mittapalli, Sani Kizilbash, David Calligaris, James Murray, Ling Cen, Karen E. Parrish
Supplemental Figure 1. MALDI FTICR mass spectra selected from a pixel with maximum intensity in the MS images of liver (A) and flank tumor (B) sections showing the two first isotopes of rucaparib (peaks labelled 1 and 2, respectively). (C) MALDI FTIC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1129c787b2292e6df7e3ef3694a32e7c
https://doi.org/10.1158/1535-7163.22503525.v1
https://doi.org/10.1158/1535-7163.22503525.v1
Autor:
Wan-Hsin Lin, James Smadbeck, Michael Barrett, Ryan Feathers, Sadeghian Dorsay, Sarah Johnson, Giannoula Karagouga, Faye Harris, Stephen Murphy, Alfredo Quiñones-Hinojosa, Sani Kizilbash, Terry Burns, Kurt Jaeckle, Maciej Mrugala, Bernard Bendok, Diogo Moniz-Garcia, Shannon Fortin-Ensign, Steven Rosenfeld, Cristiane Ida, Mark Jentoft, Marcela Salomao, Lin Yang, Angela Emanuel, Janet Schaefer-Klein, Aaron Mansfield, Mitesh Borad, John Cheville, George Vasmatzis, Panos Anastasiadis
Publikováno v:
Neuro-Oncology. 24:vii213-vii214
Diffuse gliomas are aggressive brain tumors that lack effective therapies. Despite advances in the molecular characterization of gliomas, targeted treatments have failed to improve patient outcomes to date. Here, we employed a functional genomics app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7565b944dfbd0dfbd19b01ac34a9029b
https://doi.org/10.1093/neuonc/noac209.819
https://doi.org/10.1093/neuonc/noac209.819
Autor:
Jing Qian, Deanna Pafundi, William Breen, Paul Brown, Christopher Hunt, Mark Jacobson, Derek Johnson, Timothy Kaufmann, Bradley Kemp, Sani Kizilbash, Val Lowe, Michael Ruff, Jann Sarkaria, Joon Uhm, Hok Seum Wan Chan Tseung, Elizabeth Yan, Yan Zhang, Nadia Laack, Debra Brinkmann
Publikováno v:
Neuro-Oncology. 24:vii52-vii52
BACKGROUND Interpretation of serial magnetic resonance imaging (MRI) for glioblastoma following radiation therapy (RT) is complicated by difficulty differentiating tumor from treatment-related changes, even using updated RANO criteria. The incorporat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::873baa89160eb3d80355c79011ed7dfe
https://doi.org/10.1093/neuonc/noac209.205
https://doi.org/10.1093/neuonc/noac209.205
Autor:
Bryan Neth, Aditya Raghunathan, Sani Kizilbash, Joon Uhm, William Breen, Derek Johnson, David Daniels, Ugur Sener, Ivan Carabenciov, Jian Campian, Anita Mahajan, Michael Ruff
Publikováno v:
Neuro-Oncology. 24:vii144-vii144
INTRODUCTION Medulloblastomas (MB) are embryonal tumors arising in the cerebellum, predominantly affecting pediatric patients. Recognition of molecularly defined subgroups has advanced management. Factors influencing the prognosis and management of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fdf45bd26394866ce57f016e92ab8bd
https://doi.org/10.1093/neuonc/noac209.555
https://doi.org/10.1093/neuonc/noac209.555
Autor:
Sani Kizilbash, David Piccioni, Solmaz Sahebjam, John Villano, Kurt Jaeckle, Mary Welch, Xiao-Tang Kong, Matthias Holdhoff, Anita Lammers, Adam Remick, Joel Reid, Jacob Allred, John Port, Ian Lanza, Samuel McBrayer, Charles Kunos, Geoffrey Shapiro, Alex Adjei
Publikováno v:
Neuro-Oncology. 24:vii75-vii75
IDH mutant gliomas depend on glutaminase for glutamate/glutathione generation from glutamine because R-2-hydroxyglutarate inhibits branched chain amino acid transaminase mediated glutamate biosynthesis. Telaglenastat (CB-839 HCl) is a potent glutamin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a65d7891ba114c11ca3c5eab64fb1b3
https://doi.org/10.1093/neuonc/noac209.288
https://doi.org/10.1093/neuonc/noac209.288
Autor:
Omar Butt, Jiayi Huang, Jingqin Luo, Yu Tao, Roy Strowd, Deanna Hissim, Sani Kizilbash, Christopher Abraham, George Anstass, Tanner Johanns, Albert Kim, Matthew Ciorba, Milan G Chheda, Jian Campian
Publikováno v:
Neuro-Oncology. 24:vii61-vii61
INTRODUCTION Immunotherapies targeting PD-1 in recurrent glioblastoma (rGBM) have shown limited activity. We hypothesize combining therapies targeting immunosuppressive pathways with cytotoxic and antiangiogenic therapies will improve survival. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8baacb0d1ede71d4eeed58acf166377c
https://doi.org/10.1093/neuonc/noac209.242
https://doi.org/10.1093/neuonc/noac209.242
Publikováno v:
Neuro-Oncology Advances. 4:i9-i9
Gliomas may leverage alternate metabolic pathways in response to metabolism-targeted therapeutic intervention, all of which remain unexplored in the live human glioma, in situ. Defining emergent mechanisms of metabolic resistance in response to thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f03d69c6f6d7d4643ac874d5f8036e6
https://doi.org/10.1093/noajnl/vdac078.034
https://doi.org/10.1093/noajnl/vdac078.034
Autor:
Nadia Nicole, Laack, Deanna, Pafundi, S Keith, Anderson, Timothy, Kaufmann, Val, Lowe, Christopher, Hunt, Diane, Vogen, Elizabeth, Yan, Jann, Sarkaria, Paul, Brown, Sani, Kizilbash, Joon, Uhm, Michael, Ruff, Mark, Zakhary, Yan, Zhang, Maasa, Seaberg, Hok Seum, Wan Chan Tseung, Brian, Kabat, Bradley, Kemp, Debra, Brinkmann
Publikováno v:
International journal of radiation oncology, biology, physics. 110(5)
Our previous work demonstrated that 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (Patients with newly diagnosed, histologically confirmed glioblastoma aged ≥18 years without contraindications toBetween January 2014 and December 2018, 75 evaluable p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eab697b3ce8cf155e095776c016e9b91
https://pubmed.ncbi.nlm.nih.gov/33771703
https://pubmed.ncbi.nlm.nih.gov/33771703